Representations
This page is password protected.
- 29-05-2015 Jt Comm reg. FDC of cefixime + Azithromycin
- 26-05-2015 Letter to JS Commerce on Trace & Track
- 25-06-2015 Letter to Under Secretary DoP regarding Psychoactive substan...
- 25-05-2015 Letter to Health Secretary on FSSAI - Recall of Health Supplements
- 25-06-2015 Letter to Addl. Secretary (Rev) on CPS tenders
- 25-06-2015 Letter to Joint Secretary (Commerce) on FTP 2015-2020
- 20-05-2015 Letter to DCGI on labelin of Topical products
- 22-06-2015 Letter to Under Secretary, DoP on Concessional Duty
- 18-06-2015 Letter to DCGI regarding rejection of price applications in form - 1 by NPPA
- 18-05-2015 Letter to Addl. Secretary Revenue regarding online registration of NDPS
- 14-05-2015 Letter to President, MCI
- 13-05-2015 Letter to JS - rejection of price application in Form - 1
- 24-04-2015 Rep to Chairman CPCB - ban on API units in Ankleshwar and Panoli
- 16-04-2015 Letter to CPCB on Installation of online minitoring facility
- 09-04-2015 Letter to Secretary, Commerce on Barcoding
- 07-04-2015 Letter to Secretary, DoP reg. settlement of old DPEA matters
- 27-03-2015 Letter to Minister of C&F on Concessional Duty
- 25-03-2015 Letter to Joint Secretary, DoP on Bulk Drug industry
- 25-03-2015 Dr. Harshdeep Kamble - Revision of GMP Certificate
- 20-03-2015 Letter to Chairman NPPA on ED
- 19-03-2015 Leter to Secretary, Commerce on barcoding on mono cartons
- 19-03-2015 Letter to DCGI on D&C (2nd Amendment) Rules 2015
- 19-03-2015 Letter to JS (Health), on D&C (2nd Amendment) Rules 2015
- 19-03-2015 Rep to Commerce Secretary on barcoding on mono cartons
- 18-03-2015 Applicability of biomedical waste on APIs and pharmaceuticals rep to MPCB
- 03-03-2015 Letter to Mr. K L Sharma JS (Health) on Not of Standard Quality
- 05-03-2015 FDC of Cefixime and Azithromycin
- 25-02-2015 Various Submissions in high cost of effluent treatment in Production of bulk drugs
- 24-02-2015 IDMA Suggestions on UCPMP to DOP Secretary
- 18-02-2015 Letter to Chairman reg. OM of 13-02-2015
- 18-02-2015 Letter to Secretary, DoP reg. OM of 13-02-2015
- 18-02-2015 IDMA's recommendations to the Task Force on Communicable Diseases
- 11-02-2015 Letter to Mr K L Sharma on DC Bill - concerns
- 11-02-2015 Letter to DGFT on misinterpretation of FTP
- 11-02-2015 Letter to Director (Drugs) on Essential Narcotics Drugs
- 09-02-2015 Letter of suggestios to DCGI on D&C Rules
- 09-02-2015 Office of the Commissioner of Sales Tax
- 06-02-2015 Disinfectants in Operation Theatre & hospitals
- 05-02-2015 Letter of suggestios to JS (H) on D&C Rules
- 03-02-2015 Letter to JS (H) on FDCs
- 23-01-2015 Letter to JS MoFPI reg. Section 22
- 20-01-2015 Rep to DoP on Pruing of list of Customs, Excise Duty exemptions
- 20-01-2015 Letter to DCGI on API
- 19-01-2015 Letter to Director (H) and DCGI reg. Annexure C of D&C (Amendment) Bill 2015
- 19-01-2015 Letter to JS, MOFPI on FSSAct 2006
- 15-01-2015 Detailed Submission on Drugs and Cosmetics mendment Bill 2015
- 15-01-2015 Submission to JS on FSSA sec 22 proposed changes
- 13-01-2015 Letter to Health Minister on FSS Act 2006 & Suggestions
- 12-01-2015 Letter to DG ICMR on NLEM
- 30-12-2014 Letter to Under Secretary on FSSAct 2006-3.1.2015
- 30-12-2014 Letter to NPPA on IPDMS time limit
- 23-12-2014 Letter to DGFT on Deemed Exports
- 17-12-2014 letter to DIPP on Nitroglycerin solution
- 08-12-2014 Letter to Addl. Secretary (H)
- 08-12-2014 Letter to Chairman, NPPA
- 08-12-2014 Letter to DCG(I)
- 08-12-2014 Letter to Director (H)
- 08-12-2014 Letter to Joint Secretary (H)
- 08-12-2014 Letter to Member Secretary, NPPA
- 08-12-2014 Letter to Secretary, DoP
- 19-11-2014 Letter to NPPA on redline and ceiling pricemarkings on packs
- 12-11-2014 IDMA Submission on Union Budget 2015-16 Proposals
- 10-11-2014 rep to Secretary Health on FDCs
- 04-11-2014 Letter on Nitroglycerin to Secretary (H) and DCGI
- 03-11-2014 Representtaion to PMO on PET bottles
- 03-11-2014 Letter to US (Drugs) on PET Bottles
- 03-11-2014 Letter to JS (H) on PET bottles
- 10-10-2014 Letter to Chairma NPPA on IPDMS
- 01-10-2014 Letter to Chairman NPPA on NLEM revision
- 16-09-2014 Submission on New Drug Approvals, CTs to Prof Ranjit Roy
- 25-08-2014 IDMA suggestions to Patent Controller re revised draft guidelines for examination of patent application
- 24-07-2014 Letter to Minister of C&F
- 21-08-2014 Letter to DCGI on Reward Scheme for Whistleblowers
- 25-07-2014 Letter to Shri Lov Verma Health Secretary on FDCs
- 24-07-2014 Note to Health Secretary on Current challenges for Food & Health Supplement
- 24-07-2014 Letter to Chairman NPPA on matters re. para 10 in DPCO 2013
- 23-07-2014 Letter to Chairman NPPA on DPCO 2013 anomalies
- 21-07-2014 Strategy to strengthen our economic engagement with Cambodia Laos Myanmar and Vietnam
- 21-07-2014 Letter to Chairman NPPA on differentiated dosage forms - 21.7.2014
- 18-07-2014 to Secretary Commerce Jt Sec DGFT Director on mono cartons revert as primary packs
- 16-07-2014 submission on draft NDPS Essential Narcotic Drugs Rules 2014
- 14-07-2014 Letter to Secretary DoP on Prices notified under Para 19
- 14-07-2014 Letter to Chairman NPPA on Para 19
- 14-07-2014 IDMA Submission amendments toNDPS manufactured drugs
- 10-07-2014 Voluntary code of conduct mfgrs eph-pseph
- 10-07-2014 Proposed amendment to RCS Order - 2013
- 08-07-2014 to Sec Comm Sec Revenue DGFT DGAD on anti-dumping duties being bypassed
- 25-06-2014 - Representation to RBI
- 24-06-2014 - Representation to Medical Council of India
- 23-06-2014 Letter to Member Budget CBEC
- 17-06-2014 Rep on hard gel and soft gel pricing
- 13-06-2014 Letter to Member Budget on IDMA Stand on Pre-Budget 2014-15
- 11-06-2014 FSSAI Letters MIN Secy HEALTH Min. Food Process.
- 03-06-2014 Rep to DGFT LLC
- 29-05-2014 rep to Sec, Health re audio video recording consent
- 19-05-2014 Letter to Secretary DoP on Innovative Dosage forms
- 05-05-2014 covering letters for Finance Ministry
- 02-05-2014 Letter to DOP Secretary and NPPA Chairman Pricing of innovative dosage forms
- 01-05-2014 Letter to DCGI-FDCs
- 23-04-2014 Letter to DGFT on self certification - Barcoding
- 15-04-2014 SLAs approved FDCs - Data on Safety and Efficacy
- 11-04-2014 Letter to IPC on Amendment in IP
- 09-04-2014 Letter to DCGI on Crude imports
- 07-04-2014 rep to Commerce Secretary on implementation of Barcoding on Primary Packs
- 26-03-2014 Letter to DCGI on evaluation of FDCs
- 25-03-2014 Letter to Secretary, DoP on Innovative Dosage Form
- 25-03-2014 Letter to DCGI on GSR 176 -E
- 14-03-2014 Request to DYDC, CDSCO WZ to keep ADC offices open on 31 March 2014
- 14-03-2014 Constraints faced by exporters to get NOC from ADC Ports
- 11-03-2014 repn.to USFDA India Office
- 28-02-2014 Letter to Rev Secretary on NDPS Bill 2014
- 25-02-2014 Clarifications on Foreign Trade Policy to DoP
- 25-02-2014 Letter to Jt.DCGI and DCGI on Crude Bulk Drug imports from China
- 14-02-2014 Letter to Rev Secretary on Circular 8 of 2013 - Customs
- 13-02-2014 Letter to DCGI on Schedule H1
- 12-02-2014 Submission on AV recording for CTs consent
- 12-02-2014 Letter to Commerce Minister on USFD
- 11-2-2014 Letter to Commerce Secretary on Bank Guarantee
- 10-02-2014 Letter to DCGI on FDCs
- 04-02-2014 Letter to FSSAI on Stay
- 04-02-2014 Letter to DGFT on allowing utilization - Debit for payment of Customs Duty
- 03-02-2014 Letter to Secretary DoP on Innovative Dosage forms
- 01-02-2014 Letter to DCGI on Timeline
- 15-01-2014 IDMA Suggestions on FTP 2014-19
- 08-01-2014 Supplementary suggestions on proposed 'Phytopharmaceutical drug' under D&C Rules
- 26-12-2013 Letter to TRU on CENVAT Credit Amendment Rules
- 20-12-2013 Letter to DGHS on PET Bottles
- 10-12-2013 Letter on issueas with FSSAI to Secretary Health
- 06-12-2013 Representation to JS- Health re. Phytopharamaceutical drug draft notification
- 18-11-2013 Representation to Dept. of Revenue on RCS
- 15-11-2013 Representation to ASSAM govt. reg. draft notfn re minimum wages
- 14-11-2013 Representation to Dy CM Punjab re MRs with annexure
- 12-11-2013 Letter to Assam labour Dept request for documents re minimum
- 30-10-2013 Letter to CEO FSSAI re. extension of timeline
- 11-10-2013 Representation to Commissioner Narcotics
- 08-10-2013 Representation on Dual Purpose API retest date to Dr. Somani
- 04-10-2013 IDMA Pre-Budget 2014-15 Proposals
- 03-10-2013 Letter to DCGI on NDAC review
- 30-09-2013 Letter to Chairman NPPA on 15 days notification
- 26-08-2013 Letter to Dop on SO 2534 E notification by NPPA
- 22-08-2013 Letter to various State FDAs re. shortages of essential medicines - eg. Karnataka 22.08.13
- 16-08-2013 Representation to DCG(I) re. Pioglitazone ox Warning
- 16-08-2013 Letters submitted to DCGI on FDCs
- 09-08-2013 Representation to FDA Comm. maha re Pioglitazone Box Warning
- 28-07-2013 Representation to FSSAI Chairperson
- 11-07-2013 Representation on proposed amendments to Schedule Y - Video recording
- 25-06-2013 Pioglitazone - Safety Concerns
- 21-06-2013 IDMA-OPPI jt. representation to Addl. lab' Comm Jaipur re. RMSRU
- 21-06-2013 Submission to 2nd Task force on Transaction Costs
- 18-06-2013 Representation to FSSAI
- 11-06-2013 Representation to Secretary, DOP on DPCO 2013 - Urgent Issues
- 28-05-2013 Letter to DCGI on labeling requirement of multi-ingredient products
- 18-05-2013 Letter to FSSAI re. guidelines for product approval
- 30-04-2013 FSSAI - Nutra v/s Nutritionals
- 29-04-2013 FSSAI - Licensing of FBOs
- 25-03-2013 Representation on Price Negotiations for Patented Drugs
- 15-03-2013 Letter to MCI re. MCI Code
- 14-03-2013 Draft GSR 43 re. Amendment to Rule 122E New Drug
- 14-03-2013 Representation to DCGI re. Written Confirmation Letter on EU Directives
- 04-03-2013 Representation on Maharashtra Sales Tax Rate
- 28-02-2013 Suggestions to FSSAI on regulation of Label Claims
- 15-02-2013 Presentation to Committee on Petitions of Rajya Sabha
- 28-01-2013 Revision in CCPCPL PM norms
- 18-01-2013 Representation to FM re. CBEC circular recovery of demand during Stay
- 15-01-2013 Addendum to IDMA suggestions for Union Budget 2013-14 - re
- 14-01-2013 Witholding Price Revisions by NPPA
- 09-01-2013 Representation on draft GSR 748 dt 5-10-2012 license in gen name single ingredient
- 28-12-2012 Representation to DOP on Marketing Code
- 24-12-2012 Representation to delay implementation date of barcoding on secondary packs
